| Literature DB >> 26246404 |
Jessie W Yester1, Lauren Bryan1, Michael R Waters1, Bartosz Mierzenski1, Debolina D Biswas1, Angela S Gupta1, Reetika Bhardwaj1, Michael J Surace1, Jose M Eltit1, Sheldon Milstien1, Sarah Spiegel1, Tomasz Kordula2.
Abstract
The neuroinflammation associated with multiple sclerosis involves activation of astrocytes that secrete and respond to inflammatory mediators such as IL-1. IL-1 stimulates expression of many chemokines, including C-C motif ligand (CCL) 5, that recruit immune cells, but it also stimulates sphingosine kinase-1, an enzyme that generates sphingosine-1-phosphate (S1P), a bioactive lipid mediator essential for inflammation. We found that whereas S1P promotes IL-1-induced expression of IL-6, it inhibits IL-1-induced CCL5 expression in astrocytes. This inhibition is mediated by the S1P receptor (S1PR)-2 via an inhibitory G-dependent mechanism. Consistent with this surprising finding, infiltration of macrophages into sites of inflammation increased significantly in S1PR2(-/-) animals. However, activation of NF-κB, IFN regulatory factor-1, and MAPKs, all of which regulate CCL5 expression in response to IL-1, was not diminished by the S1P in astrocytes. Instead, S1PR2 stimulated inositol 1,4,5-trisphosphate-dependent Ca(++) release and Elk-1 phosphorylation and enhanced c-Fos expression. In our study, IL-1 induced the IFNβ production that supports CCL5 expression. An intriguing finding was that S1P induced c-Fos-inhibited CCL5 directly and also indirectly through inhibition of the IFN-β amplification loop. We propose that in addition to S1PR1, which promotes inflammation, S1PR2 mediates opposing inhibitory functions that limit CCL5 expression and diminish the recruitment of immune cells. © FASEB.Entities:
Keywords: GPCR; astrocytes; chemokines; inflammation
Mesh:
Substances:
Year: 2015 PMID: 26246404 PMCID: PMC4653053 DOI: 10.1096/fj.15-275180
Source DB: PubMed Journal: FASEB J ISSN: 0892-6638 Impact factor: 5.191